Acadian Asset Management
BIVV

Acadian Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Acadian Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,246,815
Closed -$67.2M – 1959
2017
Q4 		$67.2M Buy
1,246,815
+441,084
+55% +$24.1M 0.29% 90
2017
Q3 		$46M Buy
805,731
+351,682
+77% +$20.6M 0.2% 117
2017
Q2 		$27.3M Buy
+454,049
New +$25.9M 0.12% 164

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Acadian Asset Management's BIVV Position: Q1 2018 in Review

Acadian Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,246,815 shares — an estimated $67.2M sold.

Acadian Asset Management first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $67.2M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Acadian Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Acadian Asset Management sold 1,246,815 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $67.2M.
  • Acadian Asset Management first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Acadian Asset Management's Bioverativ Inc. Common Stock position peaked at $67.2M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Acadian Asset Management's 13F filing for Q1 2018, filed 12 Apr 2018.